EUVIMEDEUVIMED entdecken
Crossref

FSTL1 sustains glioma stem cell stemness and promotes immunosuppressive macrophage polarization in glioblastoma

Fengqi Zhou, Jincheng Tao, Huiqing Gou, Shuheng Liu, Dong Yu, Junxia Zhang, Jianxiong Ji, Ning Lin, Yingyi Wang

Cancer Letters · 2025-02 · 611 · 217400

DOI: 10.1016/j.canlet.2024.217400 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2025-02. Verfasst von Fengqi Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Department of Neurosurgery, Second Affiliate…. Hauptthemen laut MEDLINE: Follistatin-Related Proteins, Neoplastic Stem Cells, Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Priority Academic Program Development of Jiangsu Higher Education Institutions, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor-associated macrophages (TAMs) within the tumor microenvironment (TME) play a crucial role in glioblastoma (GBM) progression by interacting with glioma stem cells (GSCs). These interactions lead to the polarization of TAMs toward an M2 phenotype, which, in turn, enhances the stem-like traits and malignant progression of GSCs. Our study shows that FSTL1, a protein released by GSCs, is significantly elevated in gliomas and linked to the progression of the disease. By suppressing FSTL1 in a mouse model, we observed reduced tumor growth and a decrease in M2 macrophages. In vitro studies show that FSTL1 from GSCs promotes M2 polarization and infiltration. Importantly, GSCs utilize autocrine FSTL1 to interact with TLR2, which inhibits the endocytosis-lysosomal degradation pathway mediated by EGFR, resulting in the activation of the PI3K-AKT signaling pathway that is critical for maintaining their self-renewal. These findings underscore the importance of FSTL1 in GSC maintenance and M2 macrophage polarization, suggesting that interventions targeting the FSTL1/TLR2 pathway could provide a novel therapeutic approach for GBM patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Follistatin-Related ProteinsNeoplastic Stem CellsGlioblastomaBrain NeoplasmsTumor-Associated MacrophagesMacrophagesAnimalsHumansSignal TransductionToll-Like Receptor 2Tumor MicroenvironmentCell Line, TumorProto-Oncogene Proteins c-aktMacrophage ActivationMiceErbB ReceptorsPhenotypeCell ProliferationCell Polarity

Stichwörter der Autor:innen

FSTL1GliomaGlioma stem cellsImmune microenvironmentMacrophage polarization

Substanzen

Follistatin-Related ProteinsFSTL1 protein, humanToll-Like Receptor 2Fstl1 protein, mouseProto-Oncogene Proteins c-aktTlr2 protein, mouseErbB Receptors

Autor:innen und Institutionen

  • Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • State Key Laboratory Cultivation Base of Research, Prevention and Treatment for Oral Diseases, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
  • Department of Neurosurgery, The Affiliated Chuzhou Hospital of Anhui Medical University, The First People's Hospital of Chuzhou, Chuzhou, Anhui, China.
  • Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. Electronic address: jijx@zju.edu.cn.

Förderung

  • Priority Academic Program Development of Jiangsu Higher Education Institutions
  • National Natural Science Foundation of China

Zitieren

APA

Zhou, F., Tao, J., Gou, H., Liu, S., Yu, D., Zhang, J., Ji, J., Lin, N., & Wang, Y. (2025). FSTL1 sustains glioma stem cell stemness and promotes immunosuppressive macrophage polarization in glioblastoma. Cancer Letters, 611, 217400. https://doi.org/10.1016/j.canlet.2024.217400

Vancouver

Zhou F, Tao J, Gou H, Liu S, Yu D, Zhang J, et al. FSTL1 sustains glioma stem cell stemness and promotes immunosuppressive macrophage polarization in glioblastoma. Cancer Letters. 2025;611:217400. doi:10.1016/j.canlet.2024.217400

BibTeX
@article{Zhou2025,
  author = {Zhou, Fengqi and Tao, Jincheng and Gou, Huiqing and Liu, Shuheng and Yu, Dong and Zhang, Junxia and Ji, Jianxiong and Lin, Ning and Wang, Yingyi},
  title = {FSTL1 sustains glioma stem cell stemness and promotes immunosuppressive macrophage polarization in glioblastoma},
  journal = {Cancer Letters},
  year = {2025},
  volume = {611},
  pages = {217400},
  doi = {10.1016/j.canlet.2024.217400}
}
Kostenlos starten →